Renerve Limited (RNV) Share Price & Analysis
RNV Stock Chart & Stats
- Day’s Range
- AUD 0.09 - AUD 0.09
- 52-Week Range
- AUD 0.06 - AUD 0.22
- Previous Close
- AUD 0.09
- Volume
- N/A
- Average Volume (3M)
- 73.30K
- Market Cap
- AUD 15.62M
- Enterprise Value
- AUD 11.65M
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- N/A
- Price to Earnings (P/E)
- ―
- Beta
- 1.16
- Next Earnings
- Mar 04, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Renerve Limited News
ReNerve issues new shares and reaffirms compliance with disclosure rules
Renerve Limited ( ($AU:RNV) ) has shared an announcement. ReNerve Limited, a rapidly growing medical device company, specialises in innovative solutions for peripheral nerve injuries, including its flagship FDA-cleared NervAlign
RNV FAQ
What was Renerve Limited’s price range in the past 12 months?
What is Renerve Limited’s market cap?
When is Renerve Limited’s upcoming earnings report date?
How were Renerve Limited’s earnings last quarter?
Is Renerve Limited overvalued?
Does Renerve Limited pay dividends?
What is Renerve Limited’s EPS estimate?
How many shares outstanding does Renerve Limited have?
What happened to Renerve Limited’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Renerve Limited?
What is the TipRanks Smart Score and how is it calculated?
Renerve Limited Stock Smart Score
Company Description
Renerve Limited
ReNerve Limited, a medical device company, develops tissue-based products for peripheral nerve repair and replacement, and other related soft tissue surgical procedures in New Zealand and the United States. It develops Nerve Cuff, a bioabsorbable protective wrap used to protect repaired nerves; and Nerve Graft, an off-the-shelf nerve grafts for the repair of damaged nerves under the NervAlign brand. The company also offers dermal tissue product, a deep dermal product used in the repair of reconstructive and cosmetic surgical cases; and amniotic tissue product ranges used to aid the healing of wounds under the Empliq brand. In addition, it provides Nerve Conduit Range, a nerve conduit designed to facilitate nerve growth over short gaps between nerve ends; bionic nerve, a novel combination polymer technology; and Nerve Guide Matrix for treating more severe nerve injuries, but eliminating the need for patients to undergo additional sural nerve harvesting under the NervAlign brand that are in development phase. The company was incorporated in 2016 and is headquartered in Northcote, Australia.
- Sector
- General
- Industry
- Biotechnology
- CEO
- Julian John Chick
- Website
- renerve.com.au
- Address
- 157 Heidelberg Road, Northcote, VIC, 3070, AU
Renerve Limited (RNV) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 14 | 4 | 3 |
| Technical Analysis | 3 | 3 | 3 |
| Moving Averages | 11 | 1 | 0 |
